FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 330:1697-1702 June 16, 1994 Number 24 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background We conducted a population-based, retrospective study to examine the risk of a variety of connective-tissue diseases and other disorders after breast implantation.

Methods All women in Olmsted County, Minnesota, who received a breast implant between January 1, 1964, and December 31, 1991 (the case subjects), were studied. For each case subject, two women of the same age (within three years) from the same population who had not received a breast implant and who underwent a medical evaluation within two years of the date of the implantation in the case subject were selected as control subjects. Each woman's inpatient and outpatient medical record was reviewed for the occurrence of various connective-tissue diseases, certain other disorders thought to have an autoimmune pathogenesis (e.g., Hashimoto's thyroiditis), and cancer other than breast cancer, as well as related symptoms and abnormal results of laboratory tests. The case subjects were categorized according to whether they received implants for cosmetic reasons, for reconstruction after mastectomy for breast cancer, or for reconstruction after subcutaneous mastectomy for cancer prophylaxis. Additional control subjects (women treated for breast cancer who did not have breast reconstruction) were studied for comparison with the case subjects.

Results A total of 749 women who had received a breast implant were followed for a mean of 7.8 years, and 1498 community controls were followed for a mean of 8.3 years. In 5 case subjects, as compared with 10 subjects in the control group, one of the specified connective-tissue diseases was diagnosed (relative risk, 1.06; 95 percent confidence interval, 0.34 to 2.97). Twenty-five case subjects had signs or symptoms of arthritis, as compared with 39 control subjects (relative risk, 1.35; 95 percent confidence interval, 0.81 to 2.23). Among the various signs or symptoms examined, only morning stiffness was significantly increased among the women who had received a breast implant (relative risk, 1.81; 95 percent confidence interval, 1.11 to 2.95).

Conclusions We found no association between breast implants and the connective-tissue diseases and other disorders that were studied. .

Source Information

From the Division of Rheumatology and Internal Medicine (S.E.G.), the Department of Health Sciences Research (S.E.G., W.M.O., L.T.K., C.M.B., L.J.M.), and the Department of Surgery (J.E.W.), Mayo Clinic and Mayo Foundation, Rochester, Minn.

Address reprint requests to Dr. Gabriel at the Department of Health Sciences Research, Mayo Clinic, 200 First St. S.W., Rochester, MN 55905.

Full Text of this Article

Related Letters:

Breast Implants and Connective-Tissue Diseases
Solomon G., Espinoza L., Silverman S., Royce P. C., Naim J. O., Lanzafame R. J., van Oss C. J., Spiera R. F., Gibofsky A., Spiera H., Wallace D. J., Schwartz E., Wong O., Levine A. M., Gabriel S. E., O'Fallon W. M., Kurland L. T., Luce E. A.
Extract | Full Text  
N Engl J Med 1994; 331:1231-1235, Nov 3, 1994. Correspondence

This article has been cited by other articles:

• Levy, Y., Rotman-Pikielny, P., Ehrenfeld, M., Shoenfeld, Y. (2009). Silicone breast implantation-induced scleroderma: description of four patients and a critical review of the literature. Lupus 18: 1226-1232 [Abstract]  
• MORA, G. F. (2009). Systemic Sclerosis: Environmental Factors. The Journal of Rheumatology 36: 2383-2396 [Abstract] [Full Text]  
• McLaughlin, J. K., Lipworth, L., Fryzek, J. P., Ye, W., Tarone, R. E., Nyren, O. (2006). Long-term cancer risk among Swedish women with cosmetic breast implants: an update of a nationwide study.. JNCI J Natl Cancer Inst 98: 557-560 [Abstract] [Full Text]  
• Alam, M., Danahey, D. G. (2005). Permanent Injectables for Soft Tissue Augmentation: Avoiding Misinformation and a Reprise of the Breast Implant Debacle. Arch Facial Plast Surg 7: 370-373 [Full Text]  
• Brinton, L. A., Buckley, L. M., Dvorkina, O., Lubin, J. H., Colton, T., Murray, M. C., Hoover, R. (2004). Risk of Connective Tissue Disorders among Breast Implant Patients. Am J Epidemiol 160: 619-627 [Abstract] [Full Text]  
• Gaubitz, M., Jackisch, C., Domschke, W., Heindel, W., Pfleiderer, B. (2002). Silicone breast implants: correlation between implant ruptures, magnetic resonance spectroscopically estimated silicone presence in the liver, antibody status and clinical symptoms. Rheumatology (Oxford) 41: 129-135 [Abstract] [Full Text]  
• Kjoller, K., Friis, S., Mellemkjaer, L., McLaughlin, J. K., Winther, J. F., Lipworth, L., Blot, W. J., Fryzek, J., Olsen, J. H. (2001). Connective Tissue Disease and Other Rheumatic Conditions Following Cosmetic Breast Implantation in Denmark. Arch Intern Med 161: 973-979 [Abstract] [Full Text]  
• Brown, S. L., Middleton, M. S., Berg, W. A., Soo, M. S., Pennello, G. (2000). Prevalence of Rupture of Silicone Gel Breast Implants Revealed on MR Imaging in a Population of Women in Birmingham, Alabama. Am. J. Roentgenol. 175: 1057-1064 [Abstract] [Full Text]  
• Naim, J. O., Satoh, M., Buehner, N. A., Ippolito, K. M. L., Yoshida, H., Nusz, D., Kurtelawicz, L., Cramer, S. F., Reeves, W. H. (2000). Induction of Hypergammaglobulinemia and Macrophage Activation by Silicone Gels and Oils in Female A.SW Mice. CVI 7: 366-370 [Abstract] [Full Text]  
• Janowsky, E. C., Kupper, L. L., Hulka, B. S. (2000). Meta-Analyses of the Relation between Silicone Breast Implants and the Risk of Connective-Tissue Diseases. NEJM 342: 781-790 [Abstract] [Full Text]  
• Caskey, C. I., Berg, W. A., Hamper, U. M., Sheth, S., Chang, B. W., Anderson, N. D. (1999). Imaging Spectrum of Extracapsular Silicone: Correlation of US, MR Imaging, Mammographic, and Histopathologic Findings. RadioGraphics 19: 39-51 [Abstract] [Full Text]  
• Weinshenker, B. G (1999). Databases in MS research: pitfalls and promises. Mult Scler 5: 206-211 [Abstract]  
• Kulig, K., Felix, K. (1999). Re: Felix,K., Lin,S., Bornkamm,G.W. and Janz,S. (1998) Tetravinyl-tetramethylcyclo-tetrasiloxane (tetravinyl D4) is a mutagen in Rat2{lambda}lacI fibroblasts. Carcinogenesis, 19, 315–320. Carcinogenesis 20: 1653-1654 [Full Text]  
• Vogel, H. (1999). Pathologic findings in nerve and muscle biopsies from 47 women with silicone breast implants. Neurology 53: 293-293 [Abstract] [Full Text]  
• Roger, V V., Jacobsen, S J, Weston, S A, Gabriel, S E (1999). Sex differences in the epidemiology and outcomes of heart disease: population-based trends. Lupus 8: 346-350 [Abstract]  
• Shanklin, D R., Smalley, D. L, Atherton, J. C, Nyrén, O., Adami, H.-O., Yin, L., Josefsson, S., McLaughlin, J. K, Blot, W. J, Boice, J. D Jr, Engqvist, M., Hakelius, L. (1998). Risk of connective tissue disease among women with breast implants. BMJ 317: 470-470 [Full Text]  
• Brent, J. (1998). Silicone Breast Implants and Human Rheumatic Disease is there a Connection?. International Journal of Toxicology 17: 433-447 [Abstract]  
• Todhunter, J. A., Farrow, M. G. (1998). Current Scientific Considerations in Regard to Defining a "Silicone Syndrome"/Disease and the Formation of Silica from Silicone. International Journal of Toxicology 17: 449-463 [Abstract]  
• Lamm, S. H. (1998). Silicone Breast Implants, Breast Cancer and Specific Connective Tissue Diseases: A Systematic Review of the Data in the Epidemiological Literature. International Journal of Toxicology 17: 497-527 [Abstract]  
• Coope, C., Dennison, E. (1998). Do silicone breast implants cause connective tissue disease?. BMJ 316: 403-404 [Full Text]  
• Rosenbaum, J. T. (1997). Lessons from Litigation over Silicone Breast Implants: A Call for Activism by Scientists. Science 276: 1524-1525 [Abstract] [Full Text]  
• Cook, L. S., Daling, J. R., Voigt, L. F., deHart, M. P., Malone, K. E., Stanford, J. L., Weiss, N. S., Brinton, L. A., Gammon, M. D., Brogan, D. (1997). Characteristics of Women With and Without Breast Augmentation. JAMA 277: 1612-1617 [Abstract]  
• del Junco, D. J. (1997). More Breast Implant Prose and Cons: Contractures and Confounding: The Controversy Continues. JAMA 277: 1643-1644 [Abstract]  
• Deyo, R. A., Psaty, B. M., Simon, G., Wagner, E. H., Omenn, G. S. (1997). The Messenger under Attack -- Intimidation of Researchers by Special-Interest Groups. NEJM 336: 1176-1180 [Full Text]  
• Gabriel, S. E., Woods, J. E., O'Fallon, W. M., Beard, C. M., Kurland, L. T., Melton, L. J. (1997). Complications Leading to Surgery after Breast Implantation. NEJM 336: 677-682 [Abstract] [Full Text]  
• Mathes, S. J. (1997). Breast Implantation -- The Quest for Safety and Quality. NEJM 336: 718-719 [Full Text]  
• Black, B. (1997). Subpoenas and Science -- When Lawyers Force Their Way into the Laboratory. NEJM 336: 725-727 [Full Text]  
• Goldberg, E. P., Egilman, D. S., Stubbs, C., Barthel, H. R., Barraza, O., Meier, L. G., Sunshine, J., Greenwald, M. S., Angell, M. (1996). Evaluating the Health Risks of Breast Implants. NEJM 335: 1154-1156 [Full Text]  
• Hennekens, C. H., Lee, I-M., Cook, N. R., Hebert, P. R., Karlson, E. W., LaMotte, F., Manson, J. E., Buring, J. E. (1996). Breast Implants and Connective-Tissue Disease-Reply. JAMA 276: 103-103 [Abstract]  
• Litvak, J. (1996). Breast Implants and Connective-Tissue Disease. JAMA 276: 102-103 [Abstract]  
• Angell, M. (1996). Evaluating the Health Risks of Breast Implants: The Interplay of Medical Science, the Law, and Public Opinion. NEJM 334: 1513-1518 [Full Text]  
• GRAHAM, J. D., RHOMBERG, L. (1996). How Risks are Identified and Assessed. The ANNALS of the American Academy of Political and Social Science 545: 15-24 [Abstract]  
• Hennekens, C. H., Lee, I-M., Cook, N. R., Hebert, P. R., Karlson, E. W., LaMotte, F., Manson, J. E., Buring, J. E. (1996). Self-reported Breast Implants and Connective-Tissue Diseases in Female Health Professionals: A Retrospective Cohort Study. JAMA 275: 616-621 [Abstract]  
• Fuchs, H., Johnson, J. S., Sergent, J. S. (1995). Still More on Breast Implants and Connective-Tissue Diseases. NEJM 333: 526-526 [Full Text]  
• Sanchez-Guerrero, J., Colditz, G. A., Karlson, E. W., Hunter, D. J., Speizer, F. E., Liang, M. H. (1995). Silicone Breast Implants and the Risk of Connective-Tissue Diseases and Symptoms. NEJM 332: 1666-1670 [Abstract] [Full Text]  
• Romanelli, J. N., Solomon, G., Silverman, S., Espinoza, L. (1995). More on Breast Implants and Connective-Tissue Diseases. NEJM 332: 1306-1308 [Full Text]  
• Solomon, G., Espinoza, L., Silverman, S., Royce, P. C., Naim, J. O., Lanzafame, R. J., van Oss, C. J., Spiera, R. F., Gibofsky, A., Spiera, H., Wallace, D. J., Schwartz, E., Wong, O., Levine, A. M., Gabriel, S. E., O'Fallon, W. M., Kurland, L. T., Luce, E. A. (1994). Breast Implants and Connective-Tissue Diseases. NEJM 331: 1231-1235 [Full Text]  
• Sanchez-Guerrero, J, Liang, M H (1994). Silicone breast implants and connective tissue diseases. BMJ 309: 822-823 [Full Text]  
• (1994). DO SILICONE IMPLANTS CAUSE CONNECTIVE-TISSUE DISEASE?. JWatch General 1994: 2-2 [Full Text]  
• Angell, M. (1994). Do Breast Implants Cause Systemic Disease? -- Science in the Courtroom. NEJM 330: 1748-1749 [Full Text]